Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children.
Author(s): Adler M, McDonald PJ, Trostmann U, Keyserling C, Tack K
Affiliation(s): Belmont Health Centre, Harrow, Middlesex, UK.
Publication date & source: 2000-12, Pediatr Infect Dis J., 19(12 Suppl):S166-70.
Publication type: Clinical Trial; Multicenter Study; Randomized Controlled Trial
An investigator-blinded, randomized, multicenter study was conducted to compare the efficacy and safety of cefdinir and amoxicillin/ clavulanate (amoxicillin/CA) in the treatment of pediatric patients with acute suppurative otitis media. Patients 6 months to 12 years of age were randomized in a 1:1:1 ratio to receive cefdinir 14 mg/kg once-daily, cefdinir 7 mg/kg b.i.d., or amoxicillin/CA 13.3 mg/kg t.i.d. Test-of-cure was determined 11 to 16 days posttherapy. Of the 752 patients who entered the study, 665 (88%) completed treatment and 595 (79%) were evaluable. Response rates in the three treatment groups were similar. Overall rates of adverse events were statistically lower in the cefdinir once-daily group than in the amoxicillin/CA group. Diarrhea was the most common adverse event in all treatment groups. Cefdinir given either once-daily or twice-daily is a safe and effective treatment for pediatric patients with acute suppurative otitis media.